Are tumor cells positive for CD34 (Cluster of Differentiation 34) and STAT6 (Signal Transducer and Activator of Transcription 6) on fine needle aspiration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Tumor Cell Characteristics

  • Tumor cells in solitary fibrous tumors (SFTs) are often positive for CD34 and STAT6, as shown in studies 1, 2, 3.
  • The presence of STAT6 and CD34 can be used as diagnostic markers for SFTs, especially when combined with other immunohistochemical markers 2, 3.

Fine Needle Aspiration (FNA) Biopsy

  • FNA biopsy can be used to diagnose SFTs, but the cytomorphological features can be challenging to interpret 4, 3.
  • Immunocytochemistry (ICC) performed on cell block sections can help confirm the diagnosis of SFT by showing positivity for STAT6, CD34, and other markers 4, 3.
  • The cytomorphological features of SFT on FNA biopsy can include variable cellularity, spindle to elongated cells, and a metachromatically staining matrix material 3.

Immunohistochemical Markers

  • STAT6 is a highly sensitive marker for SFTs, with a sensitivity of 96.2% in one study 2.
  • CD34 is also a common marker for SFTs, but its sensitivity is lower than that of STAT6, at 88.7% in one study 2.
  • Other markers, such as CD99 and Bcl-2, can also be positive in SFTs, but their sensitivity and specificity may vary 2.

References

Research

Cytomorphological spectrum of solitary fibrous tumour: revisited.

Cytopathology : official journal of the British Society for Clinical Cytology, 2022

Research

Cytopathology of solitary fibrous tumor: a series of 34 cases.

Journal of the American Society of Cytopathology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.